Abstract
Introduction: The VACE pathway was introduced at St Georges Hospital in 2015. The first year’s data was presented at the Association of Breast Surgery (ABS) Conference in 2017. 93 patients were managed by VACE resulting in 17 patients being upgraded to cancer. The complexity of the pathway resulted in three patients breaching the 62 day cancer target. The longest interval in the pathway was between core biopsy and VACE. In response, VACE capacity was increased and earlier MDT discussions were introduced. This is a re-audit of our outcomes following these changes. We also present our first patient satisfaction survey results.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
